Cargando…
Rapamycin Conditioning of Dendritic Cells Differentiated from Human ES Cells Promotes a Tolerogenic Phenotype
While human embryonic stem cells (hESCs) may one day facilitate the treatment of degenerative diseases requiring cell replacement therapy, the success of regenerative medicine is predicated on overcoming the rejection of replacement tissues. Given the role played by dendritic cells (DCs) in the esta...
Autores principales: | Silk, Kathryn M., Leishman, Alison J., Nishimoto, Kevin P., Reddy, Anita, Fairchild, Paul J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303870/ https://www.ncbi.nlm.nih.gov/pubmed/22505805 http://dx.doi.org/10.1155/2012/172420 |
Ejemplares similares
-
Directed Differentiation of Human Induced Pluripotent Stem Cells into Dendritic Cells Displaying Tolerogenic Properties and Resembling the CD141(+) Subset
por: Sachamitr, Patty, et al.
Publicado: (2018) -
Comparative transcriptomic profile of tolerogenic dendritic cells differentiated with vitamin D3, dexamethasone and rapamycin
por: Navarro-Barriuso, Juan, et al.
Publicado: (2018) -
Immunotherapy with Tolerogenic Dendritic Cells Alone or in Combination with Rapamycin Does Not Reverse Diabetes in NOD Mice
por: Pujol-Autonell, Irma, et al.
Publicado: (2013) -
Antithymocyte Globulin Induces a Tolerogenic Phenotype in Human Dendritic Cells
por: Roider, Tobias, et al.
Publicado: (2016) -
Tolerogenic dendritic cell-based immunotherapy
por: Chang, Kiyuk, et al.
Publicado: (2017)